Works matching IS 10781552 AND DT 2021 AND VI 27 AND IP 7
Results: 39
Filgrastim-induced rhabdomyolysis in a healthy stem cells donor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1790, doi. 10.1177/1078155221992857
- By:
- Publication type:
- Article
Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1784, doi. 10.1177/1078155221991646
- By:
- Publication type:
- Article
Extemporaneous compounding and administration of tretinoin slurry for acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1779, doi. 10.1177/1078155221990091
- By:
- Publication type:
- Article
Not only a time-saving approach: Is it the time of subcutaneous formulation for daratumumab administration?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1751, doi. 10.1177/10781552211037974
- By:
- Publication type:
- Article
Use of docetaxel in low- and high-burden metastatic hormone-sensitive prostate cancer: A systematic review and assessment of subgroup analyses.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1743, doi. 10.1177/10781552211037322
- By:
- Publication type:
- Article
Alectinib, COVID-19 and favipiravir.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
HER-2 Neu gene: A valuable therapeutic target in metastatic mucoepidermoid carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1806, doi. 10.1177/10781552211032722
- By:
- Publication type:
- Article
Immediate reaction to ibrutinib amenable to oral desensitization.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1802, doi. 10.1177/10781552211004689
- By:
- Publication type:
- Article
Trastuzumab and pertuzumab in hemodialysis: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1799, doi. 10.1177/10781552211003641
- By:
- Publication type:
- Article
Pemigatinib-induced nail changes – A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1795, doi. 10.1177/10781552211002629
- By:
- Publication type:
- Article
Citrobacter braakii CLABSI in a hematopoietic stem cell transplant patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1792, doi. 10.1177/10781552211001423
- By:
- Publication type:
- Article
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1775, doi. 10.1177/1078155220987616
- By:
- Publication type:
- Article
Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1770, doi. 10.1177/1078155220985598
- By:
- Publication type:
- Article
Case of metastatic kaposi sarcoma successfully treated with anti-PD-1 immunotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1766, doi. 10.1177/1078155220985589
- By:
- Publication type:
- Article
Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1762, doi. 10.1177/1078155220984239
- By:
- Publication type:
- Article
Bing-Neel syndrome: A case reports.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1758, doi. 10.1177/1078155220983426
- By:
- Publication type:
- Article
Bromocriptine for the treatment of postoperative cerebellar mutism syndrome in pediatric patients: Three case reports.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1753, doi. 10.1177/1078155220982046
- By:
- Publication type:
- Article
Assessment of hospitalization rates for immune-related adverse events with immune checkpoint inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1736, doi. 10.1177/1078155220968909
- By:
- Publication type:
- Article
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1730, doi. 10.1177/1078155220968615
- By:
- Publication type:
- Article
Actual body weight dosing of temozolomide and overall survival in patients with glioblastoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1723, doi. 10.1177/1078155220968613
- By:
- Publication type:
- Article
Flat-dose granulocyte colony-stimulating factor evaluation after autologous hematopoietic stem cell transplant in multiple myeloma patients: Does one dose fit all?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1716, doi. 10.1177/1078155220968611
- By:
- Publication type:
- Article
Nivolumab treatment for metastatic thymic epithelial tumors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1710, doi. 10.1177/1078155220968150
- By:
- Publication type:
- Article
Predictive factors for carboplatin hypersensitivity reactions in gynecologic cancers: Effect of BRCA status.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1704, doi. 10.1177/1078155220967988
- By:
- Publication type:
- Article
Organization of chemotherapeutic preparations in advance: Do we save or waste money?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1699, doi. 10.1177/1078155220967981
- By:
- Publication type:
- Article
Antiemetic medication efficacy during EPOCH and R-EPOCH treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1691, doi. 10.1177/1078155220967722
- By:
- Publication type:
- Article
Safety and financial analysis of outpatient dose-adjusted EPOCH for B-cell lymphoma at a tertiary comprehensive cancer center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1684, doi. 10.1177/1078155220967080
- By:
- Publication type:
- Article
Pediatric blinatumomab preparation: Risk assessment on SmPC for software compliance.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1674, doi. 10.1177/1078155220966394
- By:
- Publication type:
- Article
Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1665, doi. 10.1177/1078155220964895
- By:
- Publication type:
- Article
Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1657, doi. 10.1177/1078155220964540
- By:
- Publication type:
- Article
Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1644, doi. 10.1177/1078155220964539
- By:
- Publication type:
- Article
Medication reconciliation in ambulatory oncology new patient clinics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1637, doi. 10.1177/1078155220964247
- By:
- Publication type:
- Article
An exploration of mercaptopurine/methotrexate tolerance during maintenance therapy in children with acute lymphoblastic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1631, doi. 10.1177/1078155220963550
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1623, doi. 10.1177/1078155220963535
- By:
- Publication type:
- Article
Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1616, doi. 10.1177/1078155220963212
- By:
- Publication type:
- Article
Introduction of biosimilar pegfilgrastim in France: Economic analysis of switching from originator.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1604, doi. 10.1177/1078155220962208
- By:
- Publication type:
- Article
Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1596, doi. 10.1177/1078155220962192
- By:
- Publication type:
- Article
Healthcare failure mode and effect analysis in the chemotherapy preparation process.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1588, doi. 10.1177/1078155220962189
- By:
- Publication type:
- Article
Assessment of Canadian patient education material for oncology pharmaceutics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1578, doi. 10.1177/1078155220960823
- By:
- Publication type:
- Article
Assessment of patients' understanding of and adherence to oral anticancer medication (OAM): Results of a cross-sectional institutional pilot study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1569, doi. 10.1177/1078155220960809
- By:
- Publication type:
- Article